Insider · CIK 0001929422

Hannah Brendan

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001929422

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-23	IRLAIRulya Therapeutics Inc. · Employee Stock Option (Right to Buy)A Award	CBO, COO & CCO	AAward	−365K sh	—	—	365,000
2025-12-05	IRLAIRulya Therapeutics Inc.M Exercise/Conversion	CBO, COO & CCO	MExercise/Conversion	+25.3K sh	$0.94	+$23.8K	361,827
2025-12-05	IRLAIRulya Therapeutics Inc.M Exercise/Conversion	CBO, COO & CCO	MExercise/Conversion	+2,271 sh	$0.55	+$1,249.05	336,547
2025-12-05	IRLAIRulya Therapeutics Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	CBO, COO & CCO	MExercise/Conversion	−2,271 sh	—	—	45,168
2025-12-05	IRLAIRulya Therapeutics Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	CBO, COO & CCO	MExercise/Conversion	−25.3K sh	—	—	199,720
2025-06-18	IRLAIRulya Therapeutics Inc.A Award	CBO, COO & CCO	AAward	+37.7K sh	$1.20	+$45.3K	334,276
2025-06-18	IRLAIRulya Therapeutics Inc. · WarrantsA Award	CBO, COO & CCO	AAward	+37.7K sh	$0.13	+$4,717	37,736
2025-01-28	IRLAIRulya Therapeutics Inc. · Employee Stock Option (right to buy)A Award	CBO, COO & CCO	AAward	+450K sh	—	—	450,000
2024-08-21	IRLAIRulya Therapeutics Inc.P Purchase	CBO, COO & CCO	PPurchase	+23.6K sh	$0.63	+$14.8K	296,540
2024-08-21	IRLAIRulya Therapeutics Inc.P Purchase	CBO, COO & CCO	PPurchase	+2,280 sh	$0.61	+$1,390.8	267,975
2024-08-21	IRLAIRulya Therapeutics Inc.P Purchase	CBO, COO & CCO	PPurchase	+5,000 sh	$0.62	+$3,100	272,975
2024-08-20	IRLAIRulya Therapeutics Inc.P Purchase	CBO, COO & CCO	PPurchase	+2,500 sh	$0.61	+$1,525	262,271
2024-08-20	IRLAIRulya Therapeutics Inc.P Purchase	CBO, COO & CCO	PPurchase	+3,424 sh	$0.60	+$2,054.4	265,695
2024-08-19	IRLAIRulya Therapeutics Inc.P Purchase	CBO, COO & CCO	PPurchase	+2,155 sh	$0.58	+$1,249.9	259,771
2024-06-04	IRLAIRulya Therapeutics Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	CBO, COO & CCO	MExercise/Conversion	−56.1K sh	—	—	47,439
2024-06-04	IRLAIRulya Therapeutics Inc.M Exercise/Conversion	CBO, COO & CCO	MExercise/Conversion	+56.1K sh	$0.55	+$30.8K	257,616
2024-02-01	IRLAIRulya Therapeutics Inc. · Employee Stock Option (right to buy)A Award	CBO, COO & CCO	AAward	+600K sh	—	—	600,000
2023-10-24	IRLAIRulya Therapeutics Inc. · Employee Stock Option (right to buy)A Award	CBO, COO & CCO	AAward	+75K sh	—	—	75,000
2023-08-08	IRLAIRulya Therapeutics Inc.P Purchase	CBO, COO & CCO	PPurchase	+71.8K sh	$1.22	+$87.5K	201,555
2023-02-01	IRLAIRulya Therapeutics Inc. · Employee Stock Option (right to buy)A Award	CBO, COO & CCO	AAward	+225K sh	—	—	225,000
2022-05-23	IRLAIRulya Therapeutics Inc. · Employee Stock Option (right to buy)A Award	CBO, COO & CCO	AAward	+354K sh	—	—	353,656
2022-05-19	IRLAIRulya Therapeutics Inc.A Award	CBO, COO & CCO	AAward	+114K sh	—	—	129,793
2022-05-19	IRLAIRulya Therapeutics Inc.A Award	CBO, COO & CCO	AAward	+16.2K sh	—	—	16,224
2022-05-19	IRLAIRulya Therapeutics Inc. · Employee Stock Option (right to buy)A Award	CBO, COO & CCO	AAward	+104K sh	—	—	103,500

Recent filings

Accepted (ET)
Jan 234
Hannah Brendan0000912282-26-000119
SEC(opens sec.gov)
Dec 84
Hannah Brendan0000912282-25-001370
SEC(opens sec.gov)
Jun 234
Hannah Brendan0000912282-25-000697
SEC(opens sec.gov)
Feb 114
Hannah Brendan0001415889-25-003613
SEC(opens sec.gov)
Aug 214
Hannah Brendan0001415889-24-021869
SEC(opens sec.gov)
Jun 54
Hannah Brendan0001415889-24-015533
SEC(opens sec.gov)
Feb 24
Hannah Brendan0001415889-24-002379
SEC(opens sec.gov)
Oct 264
Hannah Brendan0001209191-23-053695
SEC(opens sec.gov)
Aug 94
Hannah Brendan0001209191-23-045234
SEC(opens sec.gov)
Feb 24
Hannah Brendan0001209191-23-006394
SEC(opens sec.gov)

Companies

IRulya Therapeutics Inc.CBO, COO & CCOIRLA

Address

C/O QUINCE THERAPEUTICS, INC. 611 GATEWAY BLVD., SUITE 273

SOUTH SAN FRANCISCO, CA, 94080